Dr. Filemon Dela Cruz is a physician-scientist at Memorial Sloan Kettering Cancer Center/MSK Kids who oversees preclinical testing efforts for the Department of Pediatrics. His research leverages patient-derived xenograft models to identify and validate new therapeutic strategies for pediatric sarcomas. He is involved in national drug development initiatives through the NCI PIVOT program and leads the Pediatric Research in Oncology Xenografting Consortium (PROXC).
